Funds advised by CVC acquired a 25.01% stake in Evonik Industries from RAG-Stiftung (RAG Foundation) in September 2008. In April 2013, Evonik was successfully listed on the Frankfurt Stock Exchange. CVC has remained a minority shareholder in the company since the stock exchange listing.
Evonik is the world's largest specialty chemicals company with a strong presence in the fields of Consumer Health & Nutrition, Resource Efficiency and Specialty Materials. Most of Evonik Chemicals' business lines hold leading positions in attractive markets. Evonik is active in countries around the world, with Germany as its most important market.
The company further remains a minority shareholder in companies active in energy production (Steag) and residential real estate (Vivawest). It is expected that these participations will be divested in the mid-term.
Evonik is headquartered in Essen, Germany, and employs approximately 33,650 people globally.